Search Results - "Ysrraelit, María Célica"
-
1
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Published in Biomedicines (20-02-2019)“…Multiple Sclerosis (MS) is a major cause of neurological disability, which increases predominantly during disease progression as a result of cortical and grey…”
Get full text
Journal Article -
2
Role of prolactin in B cell regulation in multiple sclerosis
Published in Journal of neuroimmunology (15-04-2014)“…Abstract The role of prolactin in MS pathogenesis was investigated. Prolactin levels were higher in MS subjects both during remission and exacerbation compared…”
Get full text
Journal Article -
3
Vitamin D-mediated immune regulation in Multiple Sclerosis
Published in Journal of the neurological sciences (15-12-2011)“…Abstract Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A protective effect of Vitamin D on…”
Get full text
Journal Article Conference Proceeding -
4
Immunomodulatory effects of Vitamin D in multiple sclerosis
Published in Brain (London, England : 1878) (01-05-2009)“…Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A protective effect of Vitamin D on multiple…”
Get full text
Journal Article -
5
Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
Published in ASN Neuro (2022)“…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) leading to demyelination and neurodegeneration. Life expectancy…”
Get full text
Book Review Journal Article -
6
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
Published in Multiple sclerosis (01-09-2023)“…Background: We aimed to assess the frequency of new asymptomatic lesions on brain and spinal imaging (magnetic resonance imaging (MRI)) and their association…”
Get full text
Journal Article -
7
Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis
Published in BMC neurology (27-08-2019)“…The Treatment Burden Questionnaire (TBQ) is a self-reported measure of the effect of treatment workload on patient wellbeing. We sought to validate the TBQ in…”
Get full text
Journal Article -
8
The Lancet Commission on the future of care and clinical research in autism
Published in The Lancet (British edition) (15-01-2022)“…Using data from a large-scale epidemiological sample (generously shared with us by the Norwegian Institute of Public Health), we provide initial examples of…”
Get full text
Journal Article -
9
-
10
Telomere length as a biomarker in multiple sclerosis
Published in Multiple sclerosis (01-09-2024)“…Background: Leukocyte telomere length (LTL) shortens with age and may be related to multiple sclerosis (MS). Objective: We hypothesize that chronologically…”
Get full text
Journal Article -
11
Performance of McDonald 2017 multiple sclerosis diagnostic criteria and evaluation of genetic ancestry in patients with a first demyelinating event in Argentina
Published in Multiple sclerosis (01-04-2023)“…Background: Information on performance of multiple sclerosis (MS) diagnostic criteria is scarce for populations from Latin America, Asia, or the Caribbean…”
Get full text
Journal Article -
12
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
Published in Neurological sciences (01-02-2024)“…We aimed to evaluate the incidence of SARS-CoV-2 breakthrough infection of SARS-CoV-2 vaccines in people with MS (PwMS) on high-efficacy disease-modifying…”
Get full text
Journal Article -
13
The central vein sign is present in most infratentorial multiple sclerosis plaques
Published in Multiple sclerosis and related disorders (01-02-2022)“…•Optimized SWAN is sensitive to infratentorial multiple sclerosis lesions.•The central vein sign is present in the majority of infratentorial plaques.•As in…”
Get full text
Journal Article -
14
Radiologically isolated syndrome: from biological bases to practical management
Published in Neurological sciences (01-04-2021)“…Background Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings…”
Get full text
Journal Article -
15
Consensus recommendations on the management of multiple sclerosis patients in Argentina
Published in Journal of the neurological sciences (15-02-2020)“…During the last 20 years, multiple sclerosis (MS) disease has seen major changes with new diagnostic criteria, a better identification of disease phenotypes,…”
Get full text
Journal Article -
16
Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
Published in Arquivos de neuro-psiquiatria (01-05-2021)“…The real-world effectiveness of natalizumab in people with relapsing multiple sclerosis (PwRMS) in Argentina and Chile has not been reported. To evaluate the…”
Get full text
Journal Article -
17
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients
Published in Journal of the neurological sciences (15-02-2018)“…One of the biggest challenges in multiple sclerosis (MS) is the definition of treatment response/failure in order to optimize treatment decisions in affected…”
Get full text
Journal Article -
18
Rebound activity after fingolimod cessation: A case – control study
Published in Multiple sclerosis and related disorders (01-01-2022)“…•The median time to rebound activity after fingolimod discontinuation was 50 days (IQR 37.25 – 86.75).•The main reason for stopping fingolimod in this cohort…”
Get full text
Journal Article